Cancer treatment during COVID-19 pandemic

Med Oncol. 2020 May 29;37(7):58. doi: 10.1007/s12032-020-01382-w.

Abstract

Currently world is fighting with global pandemic of coronavirus disease 2019 (COVID-19). At this time of uncertainty, oncologists are struggling to provide appropriate care to cancer patients. They have to weigh risk and benefit of giving cancer treatment vs chances of getting them infected with COVID-19. As cancer patients are immunocompromised and there are high chances of exposure during hospital visits and if they get infected, outcome can be fatal. So through the column of this article, we would like to provide basic guideline in management of cancer patients during COVID-19 pandemic.

Keywords: COVID-19; Cancer patients; Pandemic.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Betacoronavirus*
  • Bone Marrow Transplantation / methods
  • Bone Marrow Transplantation / trends
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Humans
  • Neoplasms / epidemiology
  • Neoplasms / therapy*
  • Pandemics* / prevention & control
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antineoplastic Agents